Xenetic Biosciences, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Xenetic Biosciences, Inc. on April 24, 2017. The company is incorporated in Nevada and operates as an emerging growth company. The report details corporate governance updates regarding officer appointments and the scheduling of the 2017 Annual Meeting of Stockholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate events and does not contain financial performance data.
Material Changes
- Officer Appointment: On April 24, 2017, the Board of Directors appointed James F. Parslow as the Company's principal accounting officer, effective immediately. Mr. Parslow continues to serve as Chief Financial Officer and principal financial officer.
- Annual Meeting Scheduling: The 2017 Annual Meeting of Stockholders is scheduled for July 18, 2017.
- Record Date: The record date for determining stockholders entitled to vote at the Annual Meeting is set as the close of business on May 23, 2017.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. No specific risks or contingencies were disclosed in this report. The appointment of Mr. Parslow was not made pursuant to any arrangements requiring disclosure under Item 404(a) of Regulation S-K, and his compensation will not change due to this new designation.
Investor Verification Checklist
- Verify the qualifications and background of James F. Parslow in his new role as principal accounting officer.
- Confirm the deadline for submitting stockholder proposals or director nominations, which is May 8, 2017.
- Review the Company's Amended and Restated Bylaws to ensure compliance with nomination procedures for the July 18, 2017 Annual Meeting.
- Note that this filing does not contain updated financial statements; refer to the most recent 10-K or 10-Q for financial data.